Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
583
mi
from
San Antonio, TX
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
583
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1357
mi
from
South Burlington, VT
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1357
mi
from
South Burlington, VT
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1114
mi
from
Henrico, VA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1114
mi
from
Henrico, VA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1444
mi
from
Bellingham, WA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1444
mi
from
Bellingham, WA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1410
mi
from
Seattle, WA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1385
mi
from
Vancouver, WA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1385
mi
from
Vancouver, WA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
629
mi
from
Greenfield, WI
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
629
mi
from
Greenfield, WI
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
574
mi
from
Madison, WI
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
574
mi
from
Madison, WI
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
630
mi
from
Milwaukee, WI
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
630
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
1014
mi
from
Hamilton,
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
1014
mi
from
Hamilton,
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1147
mi
from
Mission Viejo, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1147
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1182
mi
from
Rolling Hills Estates, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1182
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
418
mi
from
Saint Louis, MO
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
418
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Call for Information (Investigational Site 0061)
1257
mi
from
Ocean City, NJ
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Call for Information (Investigational Site 0061)
1257
mi
from
Ocean City, NJ
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
858
mi
from
Asheville, NC
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
858
mi
from
Asheville, NC
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
332
mi
from
Plano, TX
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
332
mi
from
Plano, TX
Click here to add this to my saved trials
Study of Binocular Computer Activities for Treatment of Amblyopia
Study of Binocular Computer Activities for Treatment of Amblyopia
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
Study of Binocular Computer Activities for Treatment of Amblyopia
Study of Binocular Computer Activities for Treatment of Amblyopia
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of Binocular Computer Activities for Treatment of Amblyopia
Study of Binocular Computer Activities for Treatment of Amblyopia
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital, University of Washington
1410
mi
from
Seattle, WA
Study of Binocular Computer Activities for Treatment of Amblyopia
Study of Binocular Computer Activities for Treatment of Amblyopia
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital, University of Washington
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial .
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston/The Medical Center
569
mi
from
Houston, TX
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial .
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston/The Medical Center
569
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial .
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston/Katy office
561
mi
from
Katy, TX
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial .
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston/Katy office
561
mi
from
Katy, TX
Click here to add this to my saved trials
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial .
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
535
mi
from
The Woodlands, TX
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema in Subjects Who Completed the Three Year VISTA-DME Trial .
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
535
mi
from
The Woodlands, TX
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10021
850
mi
from
Phoenix, AZ
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10021
850
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10044
833
mi
from
Tucson, AZ
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10044
833
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10006
1155
mi
from
Arcadia, CA
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10006
1155
mi
from
Arcadia, CA
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10004
1175
mi
from
Beverly Hills, CA
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10004
1175
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10007
1074
mi
from
Palm Desert, CA
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10007
1074
mi
from
Palm Desert, CA
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site: US10559
1281
mi
from
Sacramento, CA
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site: US10559
1281
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10031
1220
mi
from
Santa Ana, CA
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10031
1220
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10029
421
mi
from
Golden, CO
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10029
421
mi
from
Golden, CO
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US00007
1320
mi
from
Miami, FL
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US00007
1320
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10005
1147
mi
from
Winter Haven, FL
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10005
1147
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10036
931
mi
from
Augusta, GA
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10036
931
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10021
1443
mi
from
Boston, MA
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10021
1443
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10030
261
mi
from
Omaha, NE
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10030
261
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10027
1196
mi
from
Reno, NV
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10027
1196
mi
from
Reno, NV
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10016
618
mi
from
Nashville, TN
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10016
618
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10010
381
mi
from
Abilene, TX
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10010
381
mi
from
Abilene, TX
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10015
515
mi
from
Austin, TX
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10015
515
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10009
572
mi
from
Houston, TX
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10009
572
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10030
800
mi
from
McAllen, TX
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10030
800
mi
from
McAllen, TX
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US00068
576
mi
from
San Antonio, TX
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US00068
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Site US10017
1053
mi
from
Charlottesville, VA
A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Site US10017
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration
Prospective Double-blind Randomized Study to Evaluate Lucentis for Prophylaxis Against the Conversion to Neovascular Age-related Macular Degeneration (AMD) in High-risk Eyes (Let's ProTECT AMD Eyes)
Status: Enrolling
Updated:  12/31/1969
NJ Retina (Retina Associates of New Jersey)
1286
mi
from
Teaneck, NJ
Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration
Prospective Double-blind Randomized Study to Evaluate Lucentis for Prophylaxis Against the Conversion to Neovascular Age-related Macular Degeneration (AMD) in High-risk Eyes (Let's ProTECT AMD Eyes)
Status: Enrolling
Updated: 12/31/1969
NJ Retina (Retina Associates of New Jersey)
1286
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration
Prospective Double-blind Randomized Study to Evaluate Lucentis for Prophylaxis Against the Conversion to Neovascular Age-related Macular Degeneration (AMD) in High-risk Eyes (Let's ProTECT AMD Eyes)
Status: Enrolling
Updated:  12/31/1969
NJ Retina (Retina Associates of New Jersey)
1272
mi
from
Vauxhall, NJ
Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration
Prospective Double-blind Randomized Study to Evaluate Lucentis for Prophylaxis Against the Conversion to Neovascular Age-related Macular Degeneration (AMD) in High-risk Eyes (Let's ProTECT AMD Eyes)
Status: Enrolling
Updated: 12/31/1969
NJ Retina (Retina Associates of New Jersey)
1272
mi
from
Vauxhall, NJ
Click here to add this to my saved trials
Efficacy and Safety of RTH258 Versus Aflibercept
A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 Versus Aflibercept in Subjects With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Contact Alcon Call Center for Trial Locations
353
mi
from
Fort Worth, TX
Efficacy and Safety of RTH258 Versus Aflibercept
A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 Versus Aflibercept in Subjects With Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Contact Alcon Call Center for Trial Locations
353
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Retinal Therapy Guided by 3D OCT Image Analysis
Retinal Therapy Guided by 3D OCT Image Analysis
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals Dept of Ophthalmology
429
mi
from
Iowa City, IA
Retinal Therapy Guided by 3D OCT Image Analysis
Retinal Therapy Guided by 3D OCT Image Analysis
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals Dept of Ophthalmology
429
mi
from
Iowa City, IA
Click here to add this to my saved trials
Handling Comparison Between Two Contact Lens Types
Status: Enrolling
Updated:  12/31/1969
Baymeadows Vision Center
1055
mi
from
Jacksonville, FL
Handling Comparison Between Two Contact Lens Types
Status: Enrolling
Updated: 12/31/1969
Baymeadows Vision Center
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Handling Comparison Between Two Contact Lens Types
Status: Enrolling
Updated:  12/31/1969
Eye Elements Eyecare
1055
mi
from
Jacksonville, FL
Handling Comparison Between Two Contact Lens Types
Status: Enrolling
Updated: 12/31/1969
Eye Elements Eyecare
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Handling Comparison Between Two Contact Lens Types
Status: Enrolling
Updated:  12/31/1969
Vistakon Research Clinic
1055
mi
from
Jacksonville, FL
Handling Comparison Between Two Contact Lens Types
Status: Enrolling
Updated: 12/31/1969
Vistakon Research Clinic
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Handling Comparison Between Two Contact Lens Types
Status: Enrolling
Updated:  12/31/1969
Golden Family Eyecare
1145
mi
from
Sarasota, FL
Handling Comparison Between Two Contact Lens Types
Status: Enrolling
Updated: 12/31/1969
Golden Family Eyecare
1145
mi
from
Sarasota, FL
Click here to add this to my saved trials